Skip to Content

Principal Healthcare Innovators ETF BTEC

Medalist Rating as of | See Principal Investment Hub

Morningstar’s Analysis BTEC

Will BTEC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Principal Healthcare Innovators ETF's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BTEC

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 27.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alnylam Pharmaceuticals Inc

5.42 797,019
Healthcare

Moderna Inc

3.56 523,514
Healthcare

Sarepta Therapeutics Inc

3.15 463,005
Healthcare

Natera Inc

2.96 435,508
Healthcare

Illumina Inc

2.51 368,901
Healthcare

Catalent Inc

2.24 330,188
Healthcare

Insmed Inc

2.05 301,878
Healthcare

Roivant Sciences Ltd Ordinary Shares

1.86 273,926
Healthcare

Vaxcyte Inc Ordinary Shares

1.81 266,529
Healthcare

Exact Sciences Corp

1.72 253,093
Healthcare